Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (50)

Latest Posts

About This Stock More About This Stock
Ex-CEO And Chairman Of Allergan, Paul Bisaro, Is Taking The Helm At Impax Laboratories Inc
Article By: Lorimer Wilson
Tuesday, March 28, 2017 8:14 AM EDT
After handing over both the CEO and chairman reins at the company now known as Allergan longtime generics chief, Paul Bisaro, is taking the helm at Impax Laboratories Inc.
In this article: AGN, IPXL Also: NVS, TEVA, ABT, MYL
Read
Allergen/Paratek Acne Treatment Drug Passes Both Phase III Studies, Foamic Scores A Split
Article By: Lorimer Wilson
Monday, March 27, 2017 4:57 PM EDT
Allergan’s partnership with Paratek is part of an ambitious effort to buy or partner up on a long range of experimental therapies for each of its core focus areas. The Botox maker has made a big investment in aesthetics and dermatology.
In this article: AGN Also: FOMX, PRTK
Read
Allergan Has Struck A $90 Million Upfront Deal To Partner With Editas Medicine, Inc.
Article By: Lorimer Wilson
Tuesday, March 14, 2017 9:53 AM EDT
Allergan has struck a $90 million upfront deal to partner with CRISPR/Cas9 leader Editas Medicine, Inc. on up to five programs aimed at curing eye diseases.
In this article: AGN, CRSP Also: EDIT, NTLA
Read
Four Consecutive Trading Sessions With Record Highs
Article By: Marvin R Clark
Tuesday, February 14, 2017 11:31 PM EDT
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Read
E Allergan To Acquire Zeltiq Aesthetics For $2.48B, $56.50 Per Share
Article By: Jacob Maslow
Tuesday, February 14, 2017 6:39 AM EDT
Allergan announced on Monday that the company will acquire Zeltiq Aesthetics in a $2.48 billion deal. The company's failed merger with Pfizer Inc. last year has led to Allergen Chief Executive Brent Saunders acquiring several companies.
In this article: AGN, ZLTQ Also: PFE
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 1 of 1 comments